459 related articles for article (PubMed ID: 23223297)
1. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model.
Gan L; Vargas MR; Johnson DA; Johnson JA
J Neurosci; 2012 Dec; 32(49):17775-87. PubMed ID: 23223297
[TBL] [Abstract][Full Text] [Related]
2. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
5. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of astrocytic Ca
Nanclares C; Poynter J; Martell-Martinez HA; Vermilyea S; Araque A; Kofuji P; Lee MK; Covelo A
Acta Neuropathol; 2023 May; 145(5):597-610. PubMed ID: 36764943
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.
Lastres-Becker I; Ulusoy A; Innamorato NG; Sahin G; Rábano A; Kirik D; Cuadrado A
Hum Mol Genet; 2012 Jul; 21(14):3173-92. PubMed ID: 22513881
[TBL] [Abstract][Full Text] [Related]
8. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.
Gu XL; Long CX; Sun L; Xie C; Lin X; Cai H
Mol Brain; 2010 Apr; 3():12. PubMed ID: 20409326
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.
Delaidelli A; Richner M; Jiang L; van der Laan A; Bergholdt Jul Christiansen I; Ferreira N; Nyengaard JR; Vægter CB; Jensen PH; Mackenzie IR; Sorensen PH; Jan A
Acta Neuropathol Commun; 2021 Jun; 9(1):105. PubMed ID: 34092244
[TBL] [Abstract][Full Text] [Related]
11. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
12. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
13. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
[TBL] [Abstract][Full Text] [Related]
14. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Ca
Leandrou E; Chalatsa I; Anagnostou D; Machalia C; Semitekolou M; Filippa V; Makridakis M; Vlahou A; Anastasiadou E; Vekrellis K; Emmanouilidou E
Transl Neurodegener; 2024 Feb; 13(1):11. PubMed ID: 38378800
[TBL] [Abstract][Full Text] [Related]
15. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin-Proteasome System Activation.
Guo B; Zheng C; Cao J; Qiu X; Luo F; Li H; Lee SM; Yang X; Zhang G; Sun Y; Zhang Z; Wang Y
Neuromolecular Med; 2024 Apr; 26(1):9. PubMed ID: 38568291
[TBL] [Abstract][Full Text] [Related]
16. Usp14 deficiency removes α-synuclein by regulating S100A8/A9 in Parkinson's disease.
Ding L; Lu L; Zheng S; Zhang Z; Huang X; Ma R; Zhang M; Xu Z; Chen M; Guo Z; Zhu S; Gong J; Mao H; Zhang W; Xu P
Cell Mol Life Sci; 2024 May; 81(1):232. PubMed ID: 38780644
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.
Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G
J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997
[TBL] [Abstract][Full Text] [Related]
18. Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model.
Deng J; Lv E; Yang J; Gong X; Zhang W; Liang X; Wang J; Jia J; Wang X
J Neuroinflammation; 2015 May; 12():103. PubMed ID: 26016857
[TBL] [Abstract][Full Text] [Related]
19. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
[TBL] [Abstract][Full Text] [Related]
20. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
Wills J; Credle J; Haggerty T; Lee JH; Oaks AW; Sidhu A
PLoS One; 2011 Mar; 6(3):e17953. PubMed ID: 21445308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]